Johnson & Johnson

NYS : JNJ
Pharmaceuticals
New Brunswick New Jersey
2011 Revenue (US$ Millions)$65,030
2010 Revenue (US$ Millions)$61,587
Revenue Growth (%)5.59%
Net Income (US$ Millions)$9,672
Common Shares Outstanding (Millions)$2,724
Earnings Per Share (US$)$3.49
Earnings Per Share Growth (%)-26.99%
Price To Earnings Ratio19.19
Total Equity (US$ Millions)$57,080
Profit Growth (%)-27.46
Profit Margin (%)14.87%
Return On Equity (%)17.09%
Long Term Debt (US$ Millions)$12,969
Debt To Equity Ratio (%)0.23%
Market Capitalization (US$ Millions)$178,664
Total Assets (US$ Millions)$113,644
Return on Assets (%)9.4
Current Assets (US$ Millions)$54,316
Inventories (US$ Millions)$6,285
Current Liabilities (US$ Millions)$22,811
Cost of Goods Sold (US$ Millions)$20,360
Asset Turnover0.57
Inventory Turnover3.49